Claims
- 1. A method for effective gel-free analysis of single nucleotide polymorphisms (SNPs) comprising the steps of
amplifying at least one DNA segment of pre-determined size suspected of containing the SNP, wherein the amplification is performing using a first primer and a second primer, and wherein digestion of the DNA segment with a selected restriction endonuclease produces a cleaved DNA product if the SNP is present in the DNA segment; digesting the amplification product with a the selected restriction endonuclease to produce a digested DNA product; and analyzing the melting curve of the digested DNA product by Melting Curve Analysis and inferring the presence of the SNP from an inspection of melting curve profiles generated by said Melting Curve Analysis.
- 2. The method of claim 1 wherein the steps are conducted in a single tube.
- 3. The method of claim 1 wherein the first or second PCR primer, or both, contributes to the presence of a cleavage site for the selected restriction endonuclease in or near the SNP by comprising a modification at the 3′ end of said primer.
- 4. The method of claim 1 wherein the Melting Curve analysis measures decrease of double stranded DNA.
- 5. The method of claim 1 wherein the Melting Curve analysis measures increase of single stranded DNA.
- 6. The method of claim 1 wherein the Melting Curve analysis is conducted in the presence of a destablizing agent.
- 7. The method of claim 6 wherein the destabilizing agent is DMSO or formamide.
- 8. The method of claim 1 wherein the Melting Curve analysis is conducted in the presence of at least one melting point marker.
- 9. A method of making melting point markers comprising the steps of
selecting a DNA sequence having an appropriate length and sequence for the melting point required; synthesizing the two strands of the DNA sequence; mixing equimolar amounts of the two strands together to form a mixture; heating the mixture; allowing the mixture to cool in order to anneal the two strands together to form the melting point marker.
- 10. The method of claim 9 wherein the melting point marker is further labeled with at least one fluorescent dye.
- 11. The method of claim 1 wherein the McSNP is conducted on a solid phase.
- 12. A method of solid phase gel-free analysis of SNPs of two or more alleles comprising the steps of
performing multiplexing PCR analysis on a DNA sample using two PCR primers; incorporating a sequence specific tag into each of the multiplexed PCR products; subjecting the PCR products to restriction endonuclease digestion using at least one restriction endonuclease that cleaves at least one of the alleles but does not cleave at least one other of the alleles; hybridizing the digested PCR product to a DNA microarray chip spotted with a locus specific probe; fixing the digested PCR product in place using a DNA ligase enzyme to form a fixed sample; reading the fixed samples by either slowly increasing the temperature of the microarray support or by exposing the fixed samples to a denaturing chemical gradient, while monitoring the fluorescence; and discriminating the alleles based on their melting curve profiles, which are characterized by a rapid decrease in fluorescence as the fixed sample passes through its melting temperature.
- 13. The method of claim 12 wherein each PCR primer is synthesized with a phosphothioate (PTO) linkage at the immediate 3′ end.
- 14. The method of claim 12 wherein multiplex PCR is performed using one primer that has been PTO modified at the 5′ end of the primer and one unmodified primer.
- 15. A kit for performing McSNP and other melting curve methods comprising the following reagents:
at least one melting point marker; a destabilizing agent; a restriction enzyme; a dsDNA binding dye; at least one forward primer; at least one reverse primer; and TE buffer, wherein each said reagent is present in an amount suitable for performing multiple McSNP reactions.
Parent Case Info
[0001] This application claims the benefit of priority of U.S. Provisional applications Nos. 60/181,618, filed on Feb. 10, 2000, and 60/196,855, filed on Apr. 12, 2000, the contents of which are incorporated herein by reference in their entireties.
Government Interests
[0002] Pursuant to 35 U.S.C. 202(c), it is acknowledged that the U.S. Government has certain rights in the invention described herein, which was made in part with funds from the National Institutes of Health (DK53958 and HG02154).
Provisional Applications (2)
|
Number |
Date |
Country |
|
60181618 |
Feb 2000 |
US |
|
60196855 |
Apr 2000 |
US |